Vol. 30 (2) 2023
Serum metabolomic profiles and semaphorin-3A as biomarkers of diabetic retinopathy progression The Egyptian Journal of Immunology Volume 30 (2), April, 2023 Pages: 83 – 98. www.Ejimmunology.org https://doi.org/10.55133/eji.300208 Entsar R. Mokhtar1, Doaa A. Mahmoud2,...
Vol. 30 (2) 2023
Galectin-1 in Psoriatic arthritis, Psoriasis, Rheumatoid arthritis and its relation with disease activity and skin lesion The Egyptian Journal of Immunology Volume 30 (2), April, 2023 Pages: 73 – 82. www.Ejimmunology.org https://doi.org/10.55133/eji.300207 Mona M. El...
Vol. 30 (2) 2023
Kinetic of liver enzymes and serum electrolytes in HCV, HBV, and HIV negative chronic phase chronic myeloid leukemia patients treated with imatinib or nilotinib The Egyptian Journal of Immunology Volume 30 (2), April, 2023 Pages: 59 – 72. www.Ejimmunology.org...
Vol. 30 (2) 2023
In vitro expansion of human mesenchymal stem cells and hepatocytes using purified platelet derived growth factors, a potential therapeutic modality for liver fibrosis The Egyptian Journal of Immunology Volume 30 (2), April, 2023 Pages: 47 – 58. www.Ejimmunology.org...
Vol. 30 (2) 2023
Impacts of RETN genetic polymorphism on breast cancer development in Beni-Suef females, Egypt The Egyptian Journal of Immunology Volume 30 (2), April, 2023 Pages: 37 – 46. www.Ejimmunology.org https://doi.org/10.55133/eji.300204 Hanan M. Farhan1, Khadiga Abougabal1,...
Vol. 30 (2) 2023
Evaluation of serum calcitonin gene related peptide (CGRP) Level in HIV infected patients as an indicator of disease activity The Egyptian Journal of Immunology Volume 30 (2), April, 2023 Pages: 26 – 36. www.Ejimmunology.org https://doi.org/10.55133/eji.300203 Nada...
